SlideShare a Scribd company logo
1 of 12
-Sahil Verma 19085
SCREENING TESTS SPECIAL TESTS
 Whole blood
coagulation time
 Prothrombin time and
INR
 Activated partial
thromboplastin time
 Thrombin time
 Coagulation factor
assays
 Quantitative assay
COAGULATION TIME PROTHROMBIN TIME
 NORMAL – 4-9
MINUTES
 It is done by various
capillary and tube
methods
 Insensitive and non
specific hence not used
 NORMAL – 11-13
SECONDS
 It tests the adequacy of
extrinsic and common
coagulation pathways
 Increased PT values
indicates deficiency of
factor v, vii ,x
,prothrombin or
fibrinogen
 CAUSES OF
PROLONGED PT
 Administration of oral
anticoagulant drugs ,
liver disease especially
obstructive liver
disease , DIC
 (1)- BLEEDING TIME
.Normal value- 2- 6minutes
.Modified Ivy`s test
.Indicates time taken for a standardised skin
puncture to stop bleeding.
.A prolonged bleeding time may be due to-
-Thrombocytopenia
-Disorders of platelet
function
 Tourniquet test for capillary fragility is performed
to identify disorders of vascular wall integrity or
platelet disorders.
 Stasis is produced by inflating a
sphygmomanometer cuff around the arm in the
usual manner (between 80-120mm/hg).
 This moderate degree of stasis is maintained for
5minutes
 2.5cm diameter region of skin on the volar surface
of the arm 4cm distal to the antecubital fossa is
observed for petechial haemorrhages.
 Presence of more than 20 petechiae is considered a
positive test.
SCREENING TESTS SPECIAL TESTS
 Platelet count
 Bleeding time
 Examination of
fresh blood film
to see the
morphological
abnormalities of
platelets
 Platelet adhesion
test
 Aggregation test
 Electron
microscopy
 Prothrombin
consumption
index
 NORMAL COUNT 150,000 TO 450,000/mm3
 3 method are used to count the number of
platelets which include
 DIRECT METHOD- whole blood is diluted and
platelets are counted
 SEMI AUTOMATED METHOD-platelets are
subjected to sedimentation and coagulation
and then counted using electron particle
counter
 FULLY AUTOMATED METHOD-platelets are
directly counted
 If the screening test indicates a disorder of
platelet function the following tests are carried
out
 (1)-PLATELET ADHESION TEST- such as retention
in a glass bead column
 (2)-AGGREGATION TEST-which are turbidometric
techniques using ADP, collagen
 (3)-Granular content of the platelets and their
release can be assessed by ELECTRON
MICROSCOPY
 (4)- Platelet coagulation activity is measured
indirectly by PROTHROMBIN CONSUPTION INDEX
which provides information about first stage of
clotting, by measuring the amount of residual
serum prothrombin which remains after clotting
 QUALITATIVE PLATELET DISORDERS
 Most common cause of abnormal bleeding and
attributed to following causes
 (1)-Decreased platelet production
 (2)-Decreased platelet survival time
 (3)-Increased platelet sequestration by spleen
 (4)-Dilution of the platelet count by multiple
blood transfusions.
THROMBOCYTOPENIA THROMBOCYTOSIS
THROMBOCYTOPENIA
 (1)-CONGENITAL HYPOPLASIA OF THE
MEGAKARYOCYTES IN THE BONE MARROW
-Fanconi syndrome
-Tar syndrome
(2)-INFECTIVE THROMBOPOIESIS
characterize by normal to increased
marrow megakaryocytes in association with
decreased circulating platelets
Found in
- Megaloblastic anemia
- Myelodysplastic syndromes and
leukemia
IMMUNOLOGIC THROMBOCYTOPENIA
NON-IMMUNOLOGIC THROMBOCYTOPENIA
occurs due to rickettsial , bacterial, viral
infections
IDIOPATHIC THROMBOCYTOPENIA PURPURA
TYPES
Acute ITP
Chronic ITP
Recurrent ITP
Neonatal ITP
DRUG INDUCED IMMUNOLOGIC
THROMBOCYTOPENIA
POST TRANSFUSION PURPURA
 A platelet count increased above normal will
be found as a result of a variety of
circumstances.
REACTIVE
THROMBOCYTOSIS
AUTONOMOUS
THROMBOCYTOSIS
Generally responds when
the lying disorder is
treated
Marked increase in the
platelet count
Following splenectomy,
the platelet count will
rise during first
postoperative week
Associated with
thrombotic and
haemorrhagic
complications
Thrombocytosis
following major surgery
usually occurs during
first postoperative week
Common in
myeloproliferative
disorders that includes
- Polycythaemia Vera
-Myeloid metaplasia
THROMBOCYTOSIS

More Related Content

Similar to BLEEDING TESTS AND PLATLET DISORDERS.pptx

Hemostatsis & blood transfusion
Hemostatsis & blood transfusionHemostatsis & blood transfusion
Hemostatsis & blood transfusionABDUL QADEER MEMON
 
Coagulation profile final by Pandian M
Coagulation profile final by Pandian M Coagulation profile final by Pandian M
Coagulation profile final by Pandian M Pandian M
 
Approach to diagnosis of bleeding disorders
Approach to diagnosis of bleeding disordersApproach to diagnosis of bleeding disorders
Approach to diagnosis of bleeding disordersBiswajeeta Saha
 
Investigation of haemostasis.ppt kgiguffug
Investigation of haemostasis.ppt kgiguffugInvestigation of haemostasis.ppt kgiguffug
Investigation of haemostasis.ppt kgiguffugssuserfce39b
 
Presentation 22ndmay
Presentation 22ndmayPresentation 22ndmay
Presentation 22ndmayNavin Jain‬
 
Lab diagnosis of bleeding disorders Dr chithra p
Lab diagnosis of bleeding disorders Dr chithra pLab diagnosis of bleeding disorders Dr chithra p
Lab diagnosis of bleeding disorders Dr chithra pDr. Chithra P
 
investigations of bleeding disorder (1).pptx
investigations of bleeding disorder (1).pptxinvestigations of bleeding disorder (1).pptx
investigations of bleeding disorder (1).pptxRajeshSaiSajja
 
ix of hemorrhagic disease.pptx
ix of hemorrhagic disease.pptxix of hemorrhagic disease.pptx
ix of hemorrhagic disease.pptxRavi Kothari
 
Bleeding vs coagulation disorders
Bleeding vs coagulation disordersBleeding vs coagulation disorders
Bleeding vs coagulation disordersRavi Kumar Meena
 
Disseminated intravascular coagulation
Disseminated intravascular coagulationDisseminated intravascular coagulation
Disseminated intravascular coagulationQin Yang Huang
 
Investigation of bleeding disorder || bleeding disorder
Investigation of bleeding disorder ||  bleeding disorderInvestigation of bleeding disorder ||  bleeding disorder
Investigation of bleeding disorder || bleeding disorderparveen singh
 
Coagulation profile and its uses
Coagulation profile and its usesCoagulation profile and its uses
Coagulation profile and its usesAppy Akshay Agarwal
 
Understanding Haemostasis | Coagulations & Anticoagulation
Understanding Haemostasis | Coagulations & AnticoagulationUnderstanding Haemostasis | Coagulations & Anticoagulation
Understanding Haemostasis | Coagulations & AnticoagulationDr Habiba Kamarul
 
Bleeding disorder Hematology Lecture.pptx
Bleeding disorder Hematology Lecture.pptxBleeding disorder Hematology Lecture.pptx
Bleeding disorder Hematology Lecture.pptxMunmun Kulsum
 
Platelete disorders
Platelete disordersPlatelete disorders
Platelete disordersNeha Bemalgi
 

Similar to BLEEDING TESTS AND PLATLET DISORDERS.pptx (20)

Hemostatsis & blood transfusion
Hemostatsis & blood transfusionHemostatsis & blood transfusion
Hemostatsis & blood transfusion
 
PROTHROMBIN TIME.pptx
PROTHROMBIN TIME.pptxPROTHROMBIN TIME.pptx
PROTHROMBIN TIME.pptx
 
Platelets .pptx
Platelets .pptxPlatelets .pptx
Platelets .pptx
 
Coagulation profile final by Pandian M
Coagulation profile final by Pandian M Coagulation profile final by Pandian M
Coagulation profile final by Pandian M
 
Approach to diagnosis of bleeding disorders
Approach to diagnosis of bleeding disordersApproach to diagnosis of bleeding disorders
Approach to diagnosis of bleeding disorders
 
Investigation of haemostasis.ppt kgiguffug
Investigation of haemostasis.ppt kgiguffugInvestigation of haemostasis.ppt kgiguffug
Investigation of haemostasis.ppt kgiguffug
 
Presentation 22ndmay
Presentation 22ndmayPresentation 22ndmay
Presentation 22ndmay
 
Hemostasis disorders
Hemostasis disordersHemostasis disorders
Hemostasis disorders
 
Lab diagnosis of bleeding disorders Dr chithra p
Lab diagnosis of bleeding disorders Dr chithra pLab diagnosis of bleeding disorders Dr chithra p
Lab diagnosis of bleeding disorders Dr chithra p
 
investigations of bleeding disorder (1).pptx
investigations of bleeding disorder (1).pptxinvestigations of bleeding disorder (1).pptx
investigations of bleeding disorder (1).pptx
 
ix of hemorrhagic disease.pptx
ix of hemorrhagic disease.pptxix of hemorrhagic disease.pptx
ix of hemorrhagic disease.pptx
 
phlebotomy.pptx
phlebotomy.pptxphlebotomy.pptx
phlebotomy.pptx
 
Bleeding vs coagulation disorders
Bleeding vs coagulation disordersBleeding vs coagulation disorders
Bleeding vs coagulation disorders
 
Haemostasis
HaemostasisHaemostasis
Haemostasis
 
Disseminated intravascular coagulation
Disseminated intravascular coagulationDisseminated intravascular coagulation
Disseminated intravascular coagulation
 
Investigation of bleeding disorder || bleeding disorder
Investigation of bleeding disorder ||  bleeding disorderInvestigation of bleeding disorder ||  bleeding disorder
Investigation of bleeding disorder || bleeding disorder
 
Coagulation profile and its uses
Coagulation profile and its usesCoagulation profile and its uses
Coagulation profile and its uses
 
Understanding Haemostasis | Coagulations & Anticoagulation
Understanding Haemostasis | Coagulations & AnticoagulationUnderstanding Haemostasis | Coagulations & Anticoagulation
Understanding Haemostasis | Coagulations & Anticoagulation
 
Bleeding disorder Hematology Lecture.pptx
Bleeding disorder Hematology Lecture.pptxBleeding disorder Hematology Lecture.pptx
Bleeding disorder Hematology Lecture.pptx
 
Platelete disorders
Platelete disordersPlatelete disorders
Platelete disorders
 

More from SahilVerma19852

microcephaly-150601111803-lva1-app6891 (1).pptx
microcephaly-150601111803-lva1-app6891 (1).pptxmicrocephaly-150601111803-lva1-app6891 (1).pptx
microcephaly-150601111803-lva1-app6891 (1).pptxSahilVerma19852
 
1_INFORMATION BROCHURE_NExT.pdf
1_INFORMATION BROCHURE_NExT.pdf1_INFORMATION BROCHURE_NExT.pdf
1_INFORMATION BROCHURE_NExT.pdfSahilVerma19852
 
HISTORY TAKING AND EXAMINATION OF HYPERTENSION.pptx
HISTORY TAKING AND EXAMINATION OF HYPERTENSION.pptxHISTORY TAKING AND EXAMINATION OF HYPERTENSION.pptx
HISTORY TAKING AND EXAMINATION OF HYPERTENSION.pptxSahilVerma19852
 
CONGENITAL LESIONS OF laynx.pptx
CONGENITAL LESIONS OF laynx.pptxCONGENITAL LESIONS OF laynx.pptx
CONGENITAL LESIONS OF laynx.pptxSahilVerma19852
 
GENITO-URINARY FISTULA.pptx
GENITO-URINARY FISTULA.pptxGENITO-URINARY FISTULA.pptx
GENITO-URINARY FISTULA.pptxSahilVerma19852
 

More from SahilVerma19852 (10)

TREATMENT of tb.pptx
TREATMENT of tb.pptxTREATMENT of tb.pptx
TREATMENT of tb.pptx
 
jaundice 22.pptx
jaundice 22.pptxjaundice 22.pptx
jaundice 22.pptx
 
microcephaly-150601111803-lva1-app6891 (1).pptx
microcephaly-150601111803-lva1-app6891 (1).pptxmicrocephaly-150601111803-lva1-app6891 (1).pptx
microcephaly-150601111803-lva1-app6891 (1).pptx
 
1_INFORMATION BROCHURE_NExT.pdf
1_INFORMATION BROCHURE_NExT.pdf1_INFORMATION BROCHURE_NExT.pdf
1_INFORMATION BROCHURE_NExT.pdf
 
HISTORY TAKING AND EXAMINATION OF HYPERTENSION.pptx
HISTORY TAKING AND EXAMINATION OF HYPERTENSION.pptxHISTORY TAKING AND EXAMINATION OF HYPERTENSION.pptx
HISTORY TAKING AND EXAMINATION OF HYPERTENSION.pptx
 
CONGENITAL LESIONS OF laynx.pptx
CONGENITAL LESIONS OF laynx.pptxCONGENITAL LESIONS OF laynx.pptx
CONGENITAL LESIONS OF laynx.pptx
 
PSM ROLL NO 85.pptx
PSM ROLL NO 85.pptxPSM ROLL NO 85.pptx
PSM ROLL NO 85.pptx
 
STRIDOR .pptx
STRIDOR .pptxSTRIDOR .pptx
STRIDOR .pptx
 
seminar skin 85.pptx
seminar skin 85.pptxseminar skin 85.pptx
seminar skin 85.pptx
 
GENITO-URINARY FISTULA.pptx
GENITO-URINARY FISTULA.pptxGENITO-URINARY FISTULA.pptx
GENITO-URINARY FISTULA.pptx
 

Recently uploaded

URLs and Routing in the Odoo 17 Website App
URLs and Routing in the Odoo 17 Website AppURLs and Routing in the Odoo 17 Website App
URLs and Routing in the Odoo 17 Website AppCeline George
 
Kisan Call Centre - To harness potential of ICT in Agriculture by answer farm...
Kisan Call Centre - To harness potential of ICT in Agriculture by answer farm...Kisan Call Centre - To harness potential of ICT in Agriculture by answer farm...
Kisan Call Centre - To harness potential of ICT in Agriculture by answer farm...Krashi Coaching
 
Student login on Anyboli platform.helpin
Student login on Anyboli platform.helpinStudent login on Anyboli platform.helpin
Student login on Anyboli platform.helpinRaunakKeshri1
 
Paris 2024 Olympic Geographies - an activity
Paris 2024 Olympic Geographies - an activityParis 2024 Olympic Geographies - an activity
Paris 2024 Olympic Geographies - an activityGeoBlogs
 
The basics of sentences session 2pptx copy.pptx
The basics of sentences session 2pptx copy.pptxThe basics of sentences session 2pptx copy.pptx
The basics of sentences session 2pptx copy.pptxheathfieldcps1
 
mini mental status format.docx
mini    mental       status     format.docxmini    mental       status     format.docx
mini mental status format.docxPoojaSen20
 
CARE OF CHILD IN INCUBATOR..........pptx
CARE OF CHILD IN INCUBATOR..........pptxCARE OF CHILD IN INCUBATOR..........pptx
CARE OF CHILD IN INCUBATOR..........pptxGaneshChakor2
 
Beyond the EU: DORA and NIS 2 Directive's Global Impact
Beyond the EU: DORA and NIS 2 Directive's Global ImpactBeyond the EU: DORA and NIS 2 Directive's Global Impact
Beyond the EU: DORA and NIS 2 Directive's Global ImpactPECB
 
Mastering the Unannounced Regulatory Inspection
Mastering the Unannounced Regulatory InspectionMastering the Unannounced Regulatory Inspection
Mastering the Unannounced Regulatory InspectionSafetyChain Software
 
Introduction to ArtificiaI Intelligence in Higher Education
Introduction to ArtificiaI Intelligence in Higher EducationIntroduction to ArtificiaI Intelligence in Higher Education
Introduction to ArtificiaI Intelligence in Higher Educationpboyjonauth
 
Interactive Powerpoint_How to Master effective communication
Interactive Powerpoint_How to Master effective communicationInteractive Powerpoint_How to Master effective communication
Interactive Powerpoint_How to Master effective communicationnomboosow
 
A Critique of the Proposed National Education Policy Reform
A Critique of the Proposed National Education Policy ReformA Critique of the Proposed National Education Policy Reform
A Critique of the Proposed National Education Policy ReformChameera Dedduwage
 
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...EduSkills OECD
 
Hybridoma Technology ( Production , Purification , and Application )
Hybridoma Technology  ( Production , Purification , and Application  ) Hybridoma Technology  ( Production , Purification , and Application  )
Hybridoma Technology ( Production , Purification , and Application ) Sakshi Ghasle
 
Grant Readiness 101 TechSoup and Remy Consulting
Grant Readiness 101 TechSoup and Remy ConsultingGrant Readiness 101 TechSoup and Remy Consulting
Grant Readiness 101 TechSoup and Remy ConsultingTechSoup
 
Activity 01 - Artificial Culture (1).pdf
Activity 01 - Artificial Culture (1).pdfActivity 01 - Artificial Culture (1).pdf
Activity 01 - Artificial Culture (1).pdfciinovamais
 
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptx
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptxSOCIAL AND HISTORICAL CONTEXT - LFTVD.pptx
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptxiammrhaywood
 

Recently uploaded (20)

URLs and Routing in the Odoo 17 Website App
URLs and Routing in the Odoo 17 Website AppURLs and Routing in the Odoo 17 Website App
URLs and Routing in the Odoo 17 Website App
 
Kisan Call Centre - To harness potential of ICT in Agriculture by answer farm...
Kisan Call Centre - To harness potential of ICT in Agriculture by answer farm...Kisan Call Centre - To harness potential of ICT in Agriculture by answer farm...
Kisan Call Centre - To harness potential of ICT in Agriculture by answer farm...
 
Student login on Anyboli platform.helpin
Student login on Anyboli platform.helpinStudent login on Anyboli platform.helpin
Student login on Anyboli platform.helpin
 
Paris 2024 Olympic Geographies - an activity
Paris 2024 Olympic Geographies - an activityParis 2024 Olympic Geographies - an activity
Paris 2024 Olympic Geographies - an activity
 
The basics of sentences session 2pptx copy.pptx
The basics of sentences session 2pptx copy.pptxThe basics of sentences session 2pptx copy.pptx
The basics of sentences session 2pptx copy.pptx
 
mini mental status format.docx
mini    mental       status     format.docxmini    mental       status     format.docx
mini mental status format.docx
 
CARE OF CHILD IN INCUBATOR..........pptx
CARE OF CHILD IN INCUBATOR..........pptxCARE OF CHILD IN INCUBATOR..........pptx
CARE OF CHILD IN INCUBATOR..........pptx
 
Beyond the EU: DORA and NIS 2 Directive's Global Impact
Beyond the EU: DORA and NIS 2 Directive's Global ImpactBeyond the EU: DORA and NIS 2 Directive's Global Impact
Beyond the EU: DORA and NIS 2 Directive's Global Impact
 
Mastering the Unannounced Regulatory Inspection
Mastering the Unannounced Regulatory InspectionMastering the Unannounced Regulatory Inspection
Mastering the Unannounced Regulatory Inspection
 
Introduction to ArtificiaI Intelligence in Higher Education
Introduction to ArtificiaI Intelligence in Higher EducationIntroduction to ArtificiaI Intelligence in Higher Education
Introduction to ArtificiaI Intelligence in Higher Education
 
Interactive Powerpoint_How to Master effective communication
Interactive Powerpoint_How to Master effective communicationInteractive Powerpoint_How to Master effective communication
Interactive Powerpoint_How to Master effective communication
 
A Critique of the Proposed National Education Policy Reform
A Critique of the Proposed National Education Policy ReformA Critique of the Proposed National Education Policy Reform
A Critique of the Proposed National Education Policy Reform
 
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...
 
Hybridoma Technology ( Production , Purification , and Application )
Hybridoma Technology  ( Production , Purification , and Application  ) Hybridoma Technology  ( Production , Purification , and Application  )
Hybridoma Technology ( Production , Purification , and Application )
 
Mattingly "AI & Prompt Design: Structured Data, Assistants, & RAG"
Mattingly "AI & Prompt Design: Structured Data, Assistants, & RAG"Mattingly "AI & Prompt Design: Structured Data, Assistants, & RAG"
Mattingly "AI & Prompt Design: Structured Data, Assistants, & RAG"
 
Mattingly "AI & Prompt Design: The Basics of Prompt Design"
Mattingly "AI & Prompt Design: The Basics of Prompt Design"Mattingly "AI & Prompt Design: The Basics of Prompt Design"
Mattingly "AI & Prompt Design: The Basics of Prompt Design"
 
Grant Readiness 101 TechSoup and Remy Consulting
Grant Readiness 101 TechSoup and Remy ConsultingGrant Readiness 101 TechSoup and Remy Consulting
Grant Readiness 101 TechSoup and Remy Consulting
 
Activity 01 - Artificial Culture (1).pdf
Activity 01 - Artificial Culture (1).pdfActivity 01 - Artificial Culture (1).pdf
Activity 01 - Artificial Culture (1).pdf
 
Staff of Color (SOC) Retention Efforts DDSD
Staff of Color (SOC) Retention Efforts DDSDStaff of Color (SOC) Retention Efforts DDSD
Staff of Color (SOC) Retention Efforts DDSD
 
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptx
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptxSOCIAL AND HISTORICAL CONTEXT - LFTVD.pptx
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptx
 

BLEEDING TESTS AND PLATLET DISORDERS.pptx

  • 2. SCREENING TESTS SPECIAL TESTS  Whole blood coagulation time  Prothrombin time and INR  Activated partial thromboplastin time  Thrombin time  Coagulation factor assays  Quantitative assay
  • 3. COAGULATION TIME PROTHROMBIN TIME  NORMAL – 4-9 MINUTES  It is done by various capillary and tube methods  Insensitive and non specific hence not used  NORMAL – 11-13 SECONDS  It tests the adequacy of extrinsic and common coagulation pathways  Increased PT values indicates deficiency of factor v, vii ,x ,prothrombin or fibrinogen  CAUSES OF PROLONGED PT  Administration of oral anticoagulant drugs , liver disease especially obstructive liver disease , DIC
  • 4.  (1)- BLEEDING TIME .Normal value- 2- 6minutes .Modified Ivy`s test .Indicates time taken for a standardised skin puncture to stop bleeding. .A prolonged bleeding time may be due to- -Thrombocytopenia -Disorders of platelet function
  • 5.  Tourniquet test for capillary fragility is performed to identify disorders of vascular wall integrity or platelet disorders.  Stasis is produced by inflating a sphygmomanometer cuff around the arm in the usual manner (between 80-120mm/hg).  This moderate degree of stasis is maintained for 5minutes  2.5cm diameter region of skin on the volar surface of the arm 4cm distal to the antecubital fossa is observed for petechial haemorrhages.  Presence of more than 20 petechiae is considered a positive test.
  • 6. SCREENING TESTS SPECIAL TESTS  Platelet count  Bleeding time  Examination of fresh blood film to see the morphological abnormalities of platelets  Platelet adhesion test  Aggregation test  Electron microscopy  Prothrombin consumption index
  • 7.  NORMAL COUNT 150,000 TO 450,000/mm3  3 method are used to count the number of platelets which include  DIRECT METHOD- whole blood is diluted and platelets are counted  SEMI AUTOMATED METHOD-platelets are subjected to sedimentation and coagulation and then counted using electron particle counter  FULLY AUTOMATED METHOD-platelets are directly counted
  • 8.  If the screening test indicates a disorder of platelet function the following tests are carried out  (1)-PLATELET ADHESION TEST- such as retention in a glass bead column  (2)-AGGREGATION TEST-which are turbidometric techniques using ADP, collagen  (3)-Granular content of the platelets and their release can be assessed by ELECTRON MICROSCOPY  (4)- Platelet coagulation activity is measured indirectly by PROTHROMBIN CONSUPTION INDEX which provides information about first stage of clotting, by measuring the amount of residual serum prothrombin which remains after clotting
  • 9.  QUALITATIVE PLATELET DISORDERS  Most common cause of abnormal bleeding and attributed to following causes  (1)-Decreased platelet production  (2)-Decreased platelet survival time  (3)-Increased platelet sequestration by spleen  (4)-Dilution of the platelet count by multiple blood transfusions. THROMBOCYTOPENIA THROMBOCYTOSIS THROMBOCYTOPENIA
  • 10.  (1)-CONGENITAL HYPOPLASIA OF THE MEGAKARYOCYTES IN THE BONE MARROW -Fanconi syndrome -Tar syndrome (2)-INFECTIVE THROMBOPOIESIS characterize by normal to increased marrow megakaryocytes in association with decreased circulating platelets Found in - Megaloblastic anemia - Myelodysplastic syndromes and leukemia
  • 11. IMMUNOLOGIC THROMBOCYTOPENIA NON-IMMUNOLOGIC THROMBOCYTOPENIA occurs due to rickettsial , bacterial, viral infections IDIOPATHIC THROMBOCYTOPENIA PURPURA TYPES Acute ITP Chronic ITP Recurrent ITP Neonatal ITP DRUG INDUCED IMMUNOLOGIC THROMBOCYTOPENIA POST TRANSFUSION PURPURA
  • 12.  A platelet count increased above normal will be found as a result of a variety of circumstances. REACTIVE THROMBOCYTOSIS AUTONOMOUS THROMBOCYTOSIS Generally responds when the lying disorder is treated Marked increase in the platelet count Following splenectomy, the platelet count will rise during first postoperative week Associated with thrombotic and haemorrhagic complications Thrombocytosis following major surgery usually occurs during first postoperative week Common in myeloproliferative disorders that includes - Polycythaemia Vera -Myeloid metaplasia THROMBOCYTOSIS